KreLo Gmbh Medical Diagnostics was founded in April 2004 at the Biotechnology Center (TFU) in Ulm, Germany.
Prof. Dr. med. Ulrich Loos (CV) is the Managing Director.
The aims are research and development in the field of IVD (In Vitro Diagnostic) systems specially for autoimmune diseases.
The first test was developed for the direct detection of auto antibodies causing Graves`disease by means of an innovative technology (Bridge Assay)
- Development of LIA (Luminescence Immune Assays)
- Establishment of cell lines for the production of recombinant proteins by stabil gene expression
- Cloning of customer specific DNA sequences for the expression of recombinant proteins
- Preparation of reporter gene constructs with customer specific DNA sequences